TORONTO, July 10 /CNW/ - Biosign Technologies Inc. (the "Company",
"Biosign") (CNQ: BIOS) announced today that it has engaged Avro Capital Corp.
to assist with business development.
Avro will provide the Company a full range of business development
services, including sales, marketing, and corporate finance. Corporate finance
services include assisting the Company in securing equity financing on the
order of two million dollars and an optional, mid-term financing of up to ten
The term of the Agreement is twelve months, starting July 9, 2008.
For further information:
For further information: Radu Leca, President & CEO, Biosign
Technologies Inc., Phone: (416) 218-9800 ext. 222, Email: email@example.com